AstraZeneca PLC Ordinary Shares (AZN)

Depreciation & Amortization

$6.37B

TTM · Period ending: · USD

AZN logo

AZN Depreciation & Amortization

Latest reported$6.37B
AZN TTM Depreciation & Amortization ($929.02M → $6.37B)
High-resolution chart · PNG

AZN depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AstraZeneca PLC Ordinary Shares Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
6,374,665,755
5,834,665,755
5,752,665,755
4,936,000,000
5,204,000,000
5,094,000,000
5,065,000,000
5,712,992,048
5,177,992,048
5,174,992,048
5,421,992,048
5,587,208,452
5,639,208,452
5,720,208,452
5,527,208,452
6,192,000,000
7,646,000,000
7,042,000,000
6,530,000,000
5,135,000,000
3,148,000,000
3,105,000,000
3,149,000,000
3,995,000,000
3,910,000,000
3,927,000,000
3,762,000,000
3,781,000,000
3,763,000,000
3,720,000,000
3,753,000,000
3,198,000,000
3,155,000,000
3,087,000,000
3,036,000,000
2,519,000,000
2,475,000,000
2,446,000,000
2,357,000,000
2,483,000,000
2,443,000,000
2,572,000,000
2,852,000,000
3,157,000,000
3,437,000,000
3,419,000,000
3,282,000,000
4,866,000,000
4,403,000,000
4,644,000,000
4,583,000,000
2,742,000,000
3,099,000,000
2,670,000,000
2,518,000,000
2,724,000,000
2,522,000,000
2,523,000,000
2,550,000,000
2,887,000,000
2,946,000,000
2,866,000,000
2,741,000,000
2,209,000,000
2,070,000,000
2,103,000,000
2,087,000,000
2,239,000,000
2,306,000,000
2,303,000,000
2,620,000,000
2,245,000,000
2,280,000,000
2,188,000,000
1,856,000,000
1,732,000,000
1,496,000,000
1,433,000,000
1,345,000,000
1,311,000,000
1,285,000,000
1,300,000,000
1,327,000,000
1,305,000,000
1,293,000,000
1,275,000,000
1,268,000,000
1,286,000,000
1,476,838,041
1,319,551,100
1,289,999,998
1,161,538,183
916,545,219
1,002,832,160
957,383,262
1,227,112,687
1,199,267,610
1,179,954,602
1,164,267,609
790,437,015
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.